Every material Form 8-K Rogers filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Rogers Corporation reported third quarter 2025 net sales of $216.0 million, up 6.5% from the prior quarter and up from $210.3 million a year earlier. GAAP earnings were $0.48 per diluted share, compared with a loss of $(4.00) in the second quarter, while adjusted EPS was $0.90 versus $0.98 a year earlier. Fourth quarter guidance of $190 million to $205 million in net sales and GAAP EPS of $0.00 to $0.40 sits below third quarter levels, which matters for shareholders weighing the trend.
Q3 2025 net sales were $216.0 million, up 6.5% sequentially and up from $210.3 million in Q3 2024
Q3 2025 GAAP diluted EPS was $0.48 versus $(4.00) in Q2 2025; adjusted EPS was $0.90 versus $0.34 in Q2 2025 and $0.98 in Q3 2024
Q4 2025 guidance: net sales $190 million to $205 million, GAAP EPS $0.00 to $0.40, adjusted EPS $0.40 to $0.80
Q3 2025 share repurchases totaled $10.0 million; interim CEO Ali El-Haj presented the results
Rogers Corporation said its Board Chair, Peter Wallace, will not stand for re-election at the 2026 Annual Meeting of Shareholders and will leave the Board then. Director Armand Lauzon was named Chair effective October 16, 2025, and the company plans to add another independent director, with input from Starboard Value LP, which has said it will not nominate directors for the 2026 meeting.
Peter Wallace, who joined the Board in June 2010 and has been Chair or Lead Director since 2019, will step down effective the date of the 2026 Annual Meeting
Armand Lauzon, a Board member since 2023, was appointed Chair effective October 16, 2025
Rogers plans a director search for a new independent director, with input from Starboard Value LP
Filing states Mr. Wallace's decision was not the result of any disagreement with the company
Rogers reported second quarter 2025 net sales of $202.8 million, up 6.5% from the prior quarter but down from $214.2 million a year earlier. A net loss of $73.6 million, or $(4.00) per diluted share, reflected $71.8 million of non-cash impairment charges, while adjusted earnings per diluted share were $0.34. The company also announced cost reduction initiatives at its curamik business, with expected charges of $12.0 million to $20.0 million.
Q2 2025 net sales of $202.8 million, up 6.5% sequentially and down from $214.2 million in Q2 2024
GAAP net loss of $73.6 million, or $(4.00) per diluted share, including $71.8 million of non-cash impairment charges and $4.3 million of restructuring expenses
Adjusted EPS of $0.34, up from $0.27 in Q1 2025 and down from $0.69 in Q2 2024
Curamik cost initiatives expected to cut costs by more than $13.0 million annually, with $12.0 million to $20.0 million of expenses; Q3 2025 net sales guidance is $200 million to $215 million
Rogers Corporation said its President and CEO, R. Colin Gouveia, left the company on July 12, 2025, and resigned from the Board that day. The Board appointed Ali El-Haj as interim President and CEO while it searches for a permanent leader, which may take time and leaves the company's leadership in transition for shareholders.
Colin Gouveia left as President and CEO on July 12, 2025, and resigned from the Board on the same date
Ali El-Haj named Interim President and CEO; offer letter sets a $750,000 base salary and a 100% target incentive starting with the 2026 performance year
El-Haj receives a $350,000 sign-on bonus and an initial restricted stock unit grant valued at $1,500,000, vesting one year after his start date
Lawrence E. Schmid, Senior Vice President of Global Operations, also left the company on July 14, 2025
Rogers Corporation reported first quarter 2025 net sales of $190.5 million and a net loss of $1.4 million, or $(0.08) per diluted share, compared with net income of $7.8 million a year earlier. Management said results were in line with its guidance and gave second quarter 2025 net sales guidance of $190 million to $205 million, with adjusted earnings per diluted share of $0.30 to $0.70.
Q1 2025 net sales were $190.5 million, down from $213.4 million in Q1 2024 and down 0.9% from Q4 2024.
GAAP diluted loss per share was $(0.08) in Q1 2025, versus earnings of $0.42 in Q1 2024.
Adjusted earnings per diluted share were $0.27, versus $0.58 in Q1 2024.
Q2 2025 guidance: net sales of $190 million to $205 million and GAAP earnings per diluted share of $0.00 to $0.40; cash and equivalents were $175.6 million at March 31, 2025.
Rogers reported fourth quarter 2024 net sales of $192.2 million, down 8.6% from the prior quarter, and a GAAP net loss of $0.5 million, or $0.03 per diluted share. Adjusted earnings were $0.46 per diluted share, and the company guided first quarter 2025 net sales to $180 million to $195 million, with restructuring charges tied to winding down AES manufacturing in Evergem, Belgium.
Q4 2024 net sales $192.2 million versus $210.3 million in Q3 2024; GAAP operating margin was (2.6)%
Full-year 2024 net sales were $830.1 million, versus $908.4 million in 2023; full-year GAAP net income was $26.1 million
Q1 2025 guidance: net sales $180 million to $195 million; GAAP loss of $0.26 to earnings of $0.04 per diluted share; adjusted $0.10 to $0.40
Restructuring and impairment charges were $16.3 million in Q4 2024, including costs tied to the Evergem, Belgium AES wind-down
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Rogers filing is on SEC EDGAR ↗. 8-K briefs of other companies →